| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2316 |
| Trial ID | NCT04276870 |
| Disease | B-Cell Acute Lymphoblastic Leukemia | Central Nervous System Relapse | Childhood T-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Murine CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Orphan Indications for CD19 Redirected Autologous T Cells |
| Year | 2020 |
| Country | United States |
| Company sponsor | Stephan Grupp MD PhD |
| Other ID(s) | 834653, 19CT023, 19-016979 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||